Related Experiment Video

Updated: Apr 22, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

5.3K

[Inhaled nitric oxide for children with acute respiratory distress syndrome]

José Roberto Fioretto1, Mário Ferreira Carpi1, Rossano César Bonatto1

  • 1Departamento de Pediatria, Unidade de Terapia Intensiva Pediátrica, FMB, UNESP.

Revista Brasileira De Terapia Intensiva
|October 14, 2014
PubMed

Insights

Inhaled nitric oxide improves gas exchange and outcomes in children with acute respiratory distress syndrome (ARDS). This treatment is safe in intensive care units with careful monitoring, suggesting early intervention is key.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pulmonary Pharmacology

Context:

  • Acute Respiratory Distress Syndrome (ARDS) in children presents significant management challenges.
  • Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator with potential therapeutic benefits.
  • Literature review to consolidate evidence on iNO for pediatric ARDS.

Purpose:

  • To review existing literature on the use of inhaled nitric oxide in pediatric patients diagnosed with Acute Respiratory Distress Syndrome.
  • To evaluate the efficacy, safety, and optimal administration of iNO in this population.

Summary:

  • Inhaled nitric oxide (iNO) demonstrates efficacy in improving gas exchange and ventilation in pediatric ARDS.
  • It acts as a selective pulmonary vasodilator, enhancing oxygenation in severe hypoxia.
  • Safe administration is confirmed within intensive care settings under strict monitoring protocols.

Impact:

  • iNO offers a beneficial therapeutic option for improving outcomes in pediatric ARDS.
  • Highlights the importance of early treatment initiation when ARDS is potentially reversible.
  • Supports the continued use and further investigation of iNO in pediatric respiratory failure.
Abstract

More Related Videos

Intratracheal Instillation of Stem Cells in Term Neonatal Rats04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

5.4K
Analytical Techniques for Assaying Nitric Oxide Bioactivity11:28

Analytical Techniques for Assaying Nitric Oxide Bioactivity

Published on: June 18, 2012

17.7K

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
725
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
2.0K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
770
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.7K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.7K